Structural basis of the Interleukin-31 signaling complex and its inhibition.
Bloch, Y., Savvides, S.N.To be published.
Experimental Data Snapshot
Starting Model: experimental
View more details
Entity ID: 1 | |||||
|---|---|---|---|---|---|
| Molecule | Chains | Sequence Length | Organism | Details | Image |
| Nemolizumab scFv | 260 | Mus musculus | Mutation(s): 0  | ![]() | |
Entity Groups   | |||||
| Sequence Clusters | 30% Identity50% Identity70% Identity90% Identity95% Identity100% Identity | ||||
Sequence AnnotationsExpand | |||||
| |||||
Entity ID: 2 | |||||
|---|---|---|---|---|---|
| Molecule | Chains | Sequence Length | Organism | Details | Image |
| Interleukin-31 receptor subunit alpha | 261 | Homo sapiens | Mutation(s): 0  Gene Names: IL31RA, CRL3, GPL, UNQ6368/PRO21073/PRO21384 | ![]() | |
UniProt & NIH Common Fund Data Resources | |||||
Find proteins for Q8NI17 (Homo sapiens) Explore Q8NI17  Go to UniProtKB:  Q8NI17 | |||||
PHAROS:  Q8NI17 GTEx:  ENSG00000164509  | |||||
Entity Groups   | |||||
| Sequence Clusters | 30% Identity50% Identity70% Identity90% Identity95% Identity100% Identity | ||||
| UniProt Group | Q8NI17 | ||||
Glycosylation | |||||
| Glycosylation Sites: 2 | Go to GlyGen: Q8NI17-1 | ||||
Sequence AnnotationsExpand | |||||
| |||||
| Ligands 2 Unique | |||||
|---|---|---|---|---|---|
| ID | Chains | Name / Formula / InChI Key | 2D Diagram | 3D Interactions | |
| NAG Query on NAG | F [auth B], G [auth B], H [auth D], I [auth D] | 2-acetamido-2-deoxy-beta-D-glucopyranose C8 H15 N O6 OVRNDRQMDRJTHS-FMDGEEDCSA-N | |||
| A1H79 Query on A1H79 | J [auth D] | BES buffer C6 H15 N O5 S AJTVSSFTXWNIRG-UHFFFAOYSA-N | |||
| Length ( Å ) | Angle ( ˚ ) |
|---|---|
| a = 58.008 | α = 90 |
| b = 163.559 | β = 90 |
| c = 269.466 | γ = 90 |
| Software Name | Purpose |
|---|---|
| REFMAC | refinement |
| XDS | data reduction |
| XDS | data scaling |
| PHASER | phasing |
| Funding Organization | Location | Grant Number |
|---|---|---|
| Research Foundation - Flanders (FWO) | Belgium | 12S0519N |